HomeStocksZYDUSLIFE

Z

Zydus Life Science

ZYDUSLIFE Share Price

Pharmaceuticals

973.50

-12.10 (-1.23%) profit

Last Updated on 20 Dec 2024 at 15:57

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

ZYDUSLIFE Stock Performance

Markets Today

High

990.95

Low

970.30

Open at

990.10

Prev Close

973.50

Volumes

9,10,631

Avg Price

981.85

Lower Circuit

876.15

Upper Circuit

1,070.85

Last Traded Details

Quantity

2

Time

15:57:12

Price Movement

970.30
973.50
990.95
Loss 0.33%down side
up side1.76% profit

Historical Performance

3 M High

1,088.85

3 M Low

933.00

1 Yr High

1,324.30

1 Yr Low

648.15

3 Yr High

1,324.30

3 Yr Low

319.00

5 Yr High

1,324.30

5 Yr Low

202.00

1-Year Performance

648.15
973.50
1,324.30
loss0.33%down side
up side1.76% profit

ZYDUSLIFE Latest News

No news for this stock at the moment.


ZYDUSLIFE Share Price History

ZYDUSLIFE share price in last 10 trading sessions

No data

Sorry, No Data Available at this Moment!


ZYDUSLIFE Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

97,957

PE Ratio

22.90

PB Ratio

4.49

Dividend Yield

0.31

ROE

17.34

ROCE

20.43

Book Value (₹)

216.89

Face Value (₹)

1.00


Share Holding Pattern

Held BySep 2024Jun 2024Mar 2024Dec 2023Sep 2023
Promoters
74.98%74.98%74.98%74.98%74.98%
Domestic Institutional Investors (DII)
10.65%12.64%12.63%12.79%13.09%
Foreign Institutional Investors (FII)
7.52%5.59%5.72%0.00%0.00%
Public Investors
5.48%5.37%5.29%5.60%5.67%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


ZYDUSLIFE Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


ZYDUSLIFE Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA00Bullish
10-SMA00Bullish
20-SMA00Bullish
50-SMA00Bullish
100-SMA00Bullish
200-SMA00Bullish

Technical Indicators

IndicatorValueAction
RSI(14)00Bullish
ATR(14)00Bullish
STOCH(14)00Bullish
STOCH RSI(14)00Bullish
MACD(12,26)00Bullish
ADX(14)00Bullish

Summary of Technical Indicators for ZYDUSLIFE


ZYDUSLIFE Financials Summary
View By:
Revenue

In Crores

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
4,3134,4035,5266,1105,182
EBITDA

In Crores

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
1,0891,0001,6231,9861,407

Net Profit

In Crores

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
8037901,2461,483920
EPS
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
7.917.8011.6914.119.06

ZYDUSLIFE Financials

View By:

Income Statement

In Crores

Yearly StatementMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue19,83217,42415,33514,44914,367
Expenses14,16313,37811,76911,01611,470
Operating Profit5,3843,8603,3413,3872,783
Operating Profit Margin %28%22%22%24%20%
Other Income28418722546114
Interest81130127159342
Depreciation764723713670697
Profit Before Tax4,8092,5902,8382,3991,495
Tax %20%23%18%8%21%
Net Profit3,8312,0022,3262,2061,176
EPS3819442111

Balance Sheet

In Crores

Yearly Balance SheetMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital101101102102102
Reserve & Surplus19,72917,41516,89712,89010,273
Minority Interest2,2722,1732,0541,9371,335
Non Current Liabilities1,8405419151,0943,707
Current Liabilities5,3405,5277,8277,8618,269
Total Liabilities29,28125,75627,79523,88523,687
Fixed Assets12,36911,52112,18912,13312,231
Capital Work in Progress2,4231,201726783742
Investments1,2211,5473,288830765
Other Assets13,26911,48811,59310,1399,950
Total Assets29,28125,75627,79523,88523,687

Cash Flow

In Crores

Yearly Cash FlowMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating Activities3,2282,6892,1053,2942,932
Investing Activities-1,4921,542-1,018-837-1,004
Financing Activities-1,810-4,400-868-2,548-1,528
Net Cash Flow-75-170219-91399
ScanX Logo

Get In-depth View of ZYDUSLIFE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.

Use Screener

Corporate Actions

No Data

Sorry, No Corporate Actions at this Moment!


ZYDUSLIFE Revenue Growth

All values are in Crores

Profit

Revenue

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-2411,904
23.9% profit
3,442
125.05% profit
FY 2022-239,280
11.42% profit
1,529
78.25% profit
FY 2021-228,016
0.73% profit
858
-41.88% Loss

About Zydus Life Science

Zydus Lifesciences Limited, previously called Cadila Healthcare Limited, is an Indian multinational pharmaceutical company based in Ahmedabad. The company focuses on pharmaceutical product development which encompasses generics, over-the-counter drugs, and active pharmaceutical ingredients (APIs).

Read More

ZYDUSLIFE Options Snapshot

View In-depth arrow
Top 5 Traded ContractsExpiry DateLTPChangeChange %VolumeOpen InterestOI Change %

ZYDUSLIFE Futures Snapshot

View In-depth arrow
Monthly ContractsDays for ExpiryLTPChangeChange %VolumeOpen InterestOI Change %
ZYDUSLIFE DEC FUT5

971.90

-15.15-1.5338,50,20096,59,700-4.52
ZYDUSLIFE JAN FUT40

978.20

-16.15-1.6231,77,90037,02,60083.09
ZYDUSLIFE FEB FUT68

984.00

-20.40-2.0337,8001,08,0002.56

ZYDUSLIFE Similar Stocks

View All arrow

Top Gainers Today

View All Gainers arrow

Top Losers Today

View All Losers arrow

NSE Indices Today

All NSE Indices arrow

BSE Indices Today

All BSE Indices arrow

Open IPOs

View All arrow
No Data

Sorry, No Data Available at this Moment!



What’s New In The Market

At this moment, No news for this stock


FAQs

Zydus Life Science share price as of today is ₹ 973.50 as on 20 Dec 2024 at 15:57.
The 52W high of Zydus Life Science is ₹ 0.00 and 52W low is ₹ 0.00 as of 20 Dec 2024 at 15:57.
The past returns of Zydus Life Science share are -
  • Past 1 year: 46.67%
  • Past 3 years: 118.67%
  • Past 5 years: 265.77%
The PE and PB ratio of Zydus Life Science stands at 22.90 and 4.49 respectively as on 20 Dec 2024 at 15:57.
The EPS of Zydus Life Science is 9.06 for the quarter ended Sep 2024 and 38.14 for the financial year 2023-24.
The shareholding pattern of Zydus Life Science is as follows:
  • DIIs - 10.65%
  • FII - 7.52%
  • Promoters - 74.98%
  • Public Investors 5.48%
  • Goverenment - 0.00%
Yes, you can buy shares of Zydus Life Science online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Zydus Life Science stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Zydus Life Science share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Zydus Life Science.
You can easily buy the shares of Zydus Life Science even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in ZYDUSLIFE
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2024 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India.
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client in the chat section are for support purposes only, and any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Saarthi 2.0 Mobile App for Investors